Our aim was to use this approach to explore differential gene expression profiles in healthy skin keratinocyte-melanocyte co-cultures from familial melanoma patients, including both CDKN2A mutated and CDKN2A wild-type affected members, to identify novel pathways involved in melanoma susceptibility. The gene discussed is CDKN2A; the disease is melanoma.